Clinical Trials
2 trialsNCT05678348 2025-08-17
Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01066663 2023-02-22
Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dana-Farber Cancer Institute
Phase 1/2 Completed